Compare BLZR & GALT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | BLZR | GALT |
|---|---|---|
| Founded | 2025 | 2000 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Blank Checks | Biotechnology: Pharmaceutical Preparations |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 351.0M | 397.3M |
| IPO Year | 2025 | 2008 |
| Metric | BLZR | GALT |
|---|---|---|
| Price | $10.23 | $3.38 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | 70.0K | ★ 191.1K |
| Earning Date | 01-01-0001 | 11-13-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 36.84 |
| EPS | ★ N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $10.00 | $2.03 |
| 52 Week High | $10.25 | $7.13 |
| Indicator | BLZR | GALT |
|---|---|---|
| Relative Strength Index (RSI) | 49.04 | 36.98 |
| Support Level | $10.12 | $2.74 |
| Resistance Level | $10.24 | $3.56 |
| Average True Range (ATR) | 0.01 | 0.23 |
| MACD | -0.00 | -0.05 |
| Stochastic Oscillator | 0.00 | 22.09 |
Trailblazer Acquisition Corp is a blank check company.
Galectin Therapeutics Inc is a clinical-stage biopharmaceutical company. The company focuses on drug research and development to create new therapies for fibrotic disease, cancer, and selected other diseases. Its galectin-3 inhibitor is belapectin (GR-MD-02), which has been demonstrated in preclinical models to reverse liver fibrosis and cirrhosis.